{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:19:23Z","timestamp":1787678363492,"version":"build-2784847793"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2022MH060"],"award-info":[{"award-number":["ZR2022MH060"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2022MC049"],"award-info":[{"award-number":["ZR2022MC049"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2025QC1713"],"award-info":[{"award-number":["ZR2025QC1713"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018546","name":"Postdoctoral Innovation Project of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018546","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82501499"],"award-info":[{"award-number":["82501499"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471204"],"award-info":[{"award-number":["32471204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110099","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:57:41Z","timestamp":1781312261000},"page":"110099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of fluoxakalner, a novel and preferential Kv7.2\/7.3 channel opener for antinociception in mice"],"prefix":"10.1016","volume":"180","author":[{"given":"Wei","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxuan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KeWei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2026.110099_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/35036198","article-title":"Neuronal KCNQ potassium channels: physiology and role in disease","volume":"1","author":"Jentsch","year":"2000","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bioorg.2026.110099_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00583","article-title":"KCNQs: ligand- and voltage-gated potassium channels","volume":"11","author":"Abbott","year":"2020","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110099_bb0015","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1113\/jphysiol.2007.149534","article-title":"The role of IKs in atrial arrhythmogenesis","volume":"586","author":"Hothi","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.bioorg.2026.110099_bb0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-981-16-4254-8_15","article-title":"Physiological functions, biophysical properties, and regulation of KCNQ1 (K(V)7.1) potassium channels","volume":"1349","author":"Sanguinetti","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5395","key":"10.1016\/j.bioorg.2026.110099_bb0025","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1126\/science.282.5395.1890","article-title":"KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel","volume":"282","author":"Wang","year":"1998","journal-title":"Science (New York, N.Y.)"},{"issue":"18","key":"10.1016\/j.bioorg.2026.110099_bb0030","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1523\/JNEUROSCI.23-18-07227.2003","article-title":"KCNQ\/M currents in sensory neurons: significance for pain therapy","volume":"23","author":"Passmore","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bioorg.2026.110099_bb0035","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/164_2021_458","article-title":"Pharmacological activation of neuronal voltage-gated Kv7\/KCNQ\/M-channels for potential therapy of epilepsy and pain","volume":"267","author":"Liu","year":"2021"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110099_bb0040","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbrc.2008.02.152","article-title":"Skeletal muscle Kv7 (KCNQ) channels in myoblast differentiation and proliferation","volume":"369","author":"Roura-Ferrer","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110099_bb0045","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1124\/jpet.108.147785","article-title":"KCNQ modulators reveal a key role for KCNQ potassium channels in regulating the tone of rat pulmonary artery smooth muscle","volume":"329","author":"Joshi","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110099_bb0050","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s12276-021-00653-4","article-title":"Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss","volume":"53","author":"Lee","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"5349","key":"10.1016\/j.bioorg.2026.110099_bb0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.279.5349.403","article-title":"A potassium channel mutation in neonatal human epilepsy","volume":"279","author":"Biervert","year":"1998","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110099_bb0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ng0198-53","article-title":"A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family","volume":"18","author":"Charlier","year":"1998","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110099_bb0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0198-25","article-title":"A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns","volume":"18","author":"Singh","year":"1998","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110099_bb0070","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1038\/s41598-020-70212-w","article-title":"Heteromeric Kv7.2 current changes caused by loss-of-function of KCNQ2 mutations are correlated with long-term neurodevelopmental outcomes","volume":"10","author":"Lee","year":"2020","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.bioorg.2026.110099_bb0075","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.2174\/0929867324666171012122852","article-title":"Pharmacological targeting of neuronal Kv7.2\/3 channels: a focus on chemotypes and receptor sites","volume":"25","author":"Miceli","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110099_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2042098614560736","article-title":"New antiepileptic medication linked to blue discoloration of the skin and eyes","volume":"6","author":"Clark","year":"2015","journal-title":"Ther. Adv. Drug Saf."},{"issue":"16","key":"10.1016\/j.bioorg.2026.110099_bb0085","doi-asserted-by":"crossref","first-page":"11340","DOI":"10.1021\/acs.jmedchem.2c00911","article-title":"Beyond retigabine: design, synthesis, and pharmacological characterization of a potent and chemically stable neuronal Kv7 channel activator with anticonvulsant activity","volume":"65","author":"Musella","year":"2022","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110099_bb0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40263-024-01155-3","article-title":"Targeting Kv7 potassium channels for epilepsy","volume":"39","author":"Perucca","year":"2025","journal-title":"CNS Drugs"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110099_bb0095","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/cmdc.201900112","article-title":"Sulfide analogues of flupirtine and retigabine with nanomolar K(V) 7.2\/K(V) 7.3 channel opening activity","volume":"14","author":"Bock","year":"2019","journal-title":"ChemMedChem"},{"issue":"16","key":"10.1016\/j.bioorg.2026.110099_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200262","article-title":"Carba analogues of flupirtine and retigabine with improved oxidation resistance and reduced risk of quinoid metabolite formation","volume":"17","author":"Wurm","year":"2022","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110099_bb0105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/acs.chemrestox.8b00313","article-title":"An investigation into retigabine (Ezogabine) associated dyspigmentation in rat eyes by MALDI imaging mass spectrometry","volume":"32","author":"Groseclose","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bioorg.2026.110099_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117660","article-title":"Design, synthesis, and structure-activity relationship of 5,7-dimethylbenzo[d]thiazoles as novel Kv7.2\/7.3 activators with antiepileptic effects","volume":"292","author":"Zhang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110099_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116953","article-title":"Discovery of a novel K(V)7.2\/7.3 channels agonist for the treatment of neuropathic pain","volume":"280","author":"Qian","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110099_bb0120","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1111\/epi.18092","article-title":"Identification of a new retigabine derivative with improved photostability for selective activation of neuronal Kv7 channels and antiseizure activity","volume":"65","author":"Wang","year":"2024","journal-title":"Epilepsia"},{"issue":"15","key":"10.1016\/j.bioorg.2026.110099_bb0125","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1523\/JNEUROSCI.21-15-05535.2001","article-title":"Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine","volume":"21","author":"Tatulian","year":"2001","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110099_bb0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41422-020-00410-8","article-title":"Molecular basis for ligand activation of the human KCNQ2 channel","volume":"31","author":"Li","year":"2021","journal-title":"Cell Res."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2026.110099_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0021-9673(02)00064-X","article-title":"Method for measuring the logarithm of the octanol-water partition coefficient by using short octadecyl-poly(vinyl alcohol) high-performance liquid chromatography columns","volume":"952","author":"Donovan","year":"2002","journal-title":"J. Chromatogr. A"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110099_bb0140","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1074\/jbc.M115.654392","article-title":"Selective activation of nociceptor TRPV1 channel and reversal of inflammatory pain in mice by a novel coumarin derivative muralatin L from Murraya alata","volume":"291","author":"Wei","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110099_bb0145","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1021\/acs.analchem.9b04193","article-title":"Visualizing TRPA1 in the plasma membrane for rapidly screening optical control agonists via a photochromic ligand based fluorescent probe","volume":"92","author":"Qiao","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bioorg.2026.110099_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117586","article-title":"Discovery of non-electrophilic TRPA1 channel agonists with anti-nociceptive effects via rapid current desensitization","volume":"291","author":"Yang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110099_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00433","article-title":"Up-down reader: an open source program for efficiently processing 50% von Frey thresholds","volume":"9","author":"Gonzalez-Cano","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110099_bb0160","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.3390\/ijms25052901","article-title":"Eicosapentaenoic acid modulates transient receptor potential V1 expression in specific brain areas in a mouse fibromyalgia pain model","volume":"25","author":"Liao","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110099_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pbb.2013.04.014","article-title":"Anti-nociceptive effect of vitexin mediated by the opioid system in mice","volume":"109","author":"Demir \u00d6zkay","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110099_bb0170","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/molecules30030604","article-title":"Effects of biased analogues of the kappa opioid receptor agonist, U50,488, in preclinical models of pain and side effects","volume":"30","author":"van de Wetering","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110099_bb0175","doi-asserted-by":"crossref","first-page":"108439","DOI":"10.1016\/j.neuropharm.2020.108439","article-title":"Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain","volume":"185","author":"Pantouli","year":"2021","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110099_bb0180","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/aps.2016.33","article-title":"Activation of neuronal Kv7\/KCNQ\/M-channels by the opener QO58-lysine and its anti-nociceptive effects on inflammatory pain in rodents","volume":"37","author":"Teng","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110099_bb0185","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10047-024-01474-8","article-title":"A compact machine perfusion device for whole blood perfusion in isolated rat liver","volume":"28","author":"Tamaki","year":"2025","journal-title":"J. Artif. Organs"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110099_bb0190","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0090-9556(24)15258-0","article-title":"Metabolism of retigabine (D-23129), a novel anticonvulsant","volume":"27","author":"Hempel","year":"1999","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110099_bb0195","first-page":"700","article-title":"In vitro metabolism of copalic and kaurenoic acids in rat and human liver microsomes","volume":"44","author":"Mauro","year":"2021","journal-title":"Quim"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110099_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3959(94)00095-V","article-title":"The formalin test: scoring properties of the first and second phases of the pain response in rats","volume":"60","author":"Abbott","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.bioorg.2026.110099_bb0205","article-title":"Antinociceptive effects of dehydrocorydaline in mouse models of inflammatory pain involve the opioid receptor and inflammatory cytokines","volume":"6","author":"Yin","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110099_bb0210","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jamaneurol.2023.3542","article-title":"Efficacy and safety of XEN1101, a novel potassium channel opener, in adults with focal epilepsy: a phase 2b randomized clinical trial","volume":"80","author":"French","year":"2023","journal-title":"JAMA Neurol."},{"issue":"5\u20136","key":"10.1016\/j.bioorg.2026.110099_bb0215","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/17512433.2024.2337012","article-title":"A profile of azetukalner for the treatment of epilepsy: from pharmacology to potential for therapy","volume":"17","author":"Lattanzi","year":"2024","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110099_bb0220","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1111\/epi.14557","article-title":"Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development","volume":"59","author":"Bialer","year":"2018","journal-title":"Epilepsia"},{"issue":"45","key":"10.1016\/j.bioorg.2026.110099_bb0225","doi-asserted-by":"crossref","first-page":"8695","DOI":"10.1039\/C8OB02530D","article-title":"Synthesis and potassium K(V)7 channel opening activity of thioether analogues of the analgesic flupirtine","volume":"16","author":"Bock","year":"2018","journal-title":"Org. Biomol. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110099_bb0230","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.3390\/molecules29133234","article-title":"In silico methods for the discovery of Kv7.2\/7.3 channels modulators: a comprehensive review","volume":"29","author":"Stagno","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110099_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-19850-9","article-title":"Physical basis of specificity and delayed binding of a subtype selective sodium channel inhibitor","volume":"8","author":"Corry","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110099_bb0240","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-pharmtox-010919-023645","article-title":"Hormonal signaling actions on Kv7.1 (KCNQ1) channels","volume":"61","author":"Thompson","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110099_bb0245","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1080\/1061186X.2019.1608552","article-title":"Activation of K(v)7 channels with the anticonvulsant retigabine alleviates neuropathic pain behaviour in the streptozotocin rat model of diabetic neuropathy","volume":"27","author":"Djouhri","year":"2019","journal-title":"J. Drug Target."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110099_bb0250","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1089\/neu.2016.4789","article-title":"Activation of KCNQ channels suppresses spontaneous activity in dorsal root ganglion neurons and reduces chronic pain after spinal cord injury","volume":"34","author":"Wu","year":"2017","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110099_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3458.2005.tb00033.x","article-title":"Retigabine: chemical synthesis to clinical application","volume":"11","author":"Blackburn-Munro","year":"2005","journal-title":"CNS Drug Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110099_bb0260","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/00912700222011210","article-title":"Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteers","volume":"42","author":"Ferron","year":"2002","journal-title":"J. Clin. Pharmacol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:30:00Z","timestamp":1787675400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826006358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":52,"alternative-id":["S0045206826006358"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110099","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of fluoxakalner, a novel and preferential Kv7.2\/7.3 channel opener for antinociception in mice","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110099"}}